Key result
Personalized preventive approaches focus ~46% of strategies on tertiary prevention, particularly in oncology.
Why the study?
Personalised prevention is a promising tool to reduce the impact of non-communicable diseases, but the current state of evidence in this area needed clarification.
Population
121 publications including 60 primary cohort studies and 61 clinical practice directives on personalised prevention for chronic diseases
Comparison
Personalised preventive approaches across primary, secondary, and tertiary prevention levels
Design
Scoping review following Arksey-O'Malley guidelines and PRISMA-ScR checklist
Authors
Loading...
Most personalized prevention targets tertiary oncology; extends field mapping while highlighting gaps in primary CVD strategies.
This scoping review highlights a growing interest in personalised primary prevention for cardiovascular diseases and a strong focus on oncology in clinical practice directives, though most approaches currently fall under tertiary prevention.
Farina et al. (2025) conducted a review in Non-communicable diseases (n=121). Personalised preventive approaches was evaluated on Number and distribution of personalised preventive approaches across prevention levels. A scoping review of 121 publications identified 249 personalised preventive approaches, with the majority (46%) focused on tertiary prevention, particularly in oncology.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: